Are you Dr. Williamson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 38 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1454 Madison Ave W
Immokalee, FL 34142Phone+1 239-658-3196Fax+1 239-658-3175
Summary
- Dr. Jerry Williamson, MD is a board certified pediatrician in Immokalee, Florida. He is currently licensed to practice medicine in Florida. He is affiliated with NCH Baker Hospital.
Education & Training
- University of FloridaResidency, Pediatrics, 1977 - 1978
- University of Miami/Jackson Health SystemResidency, Pediatrics, 1976 - 1977
- University of Michigan Health SystemInternship, Transitional Year, 1975 - 1976
- MCP-Hahnemann College of MedicineClass of 1975
Certifications & Licensure
- FL State Medical License 1977 - 2025
- American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- 27 citationsProduction of 1-Carbon Units from Glycine Is Extensive in Healthy Men and WomenYvonne Lamers, Jerry Williamson, Douglas W. Theriaque, Jonathan J. Shuster, Lesa R. Gilbert
The Journal of Nutrition. 2009-04-01 - 41 citationsModerate Dietary Vitamin B-6 Restriction Raises Plasma Glycine and Cystathionine Concentrations While Minimally Affecting the Rates of Glycine Turnover and Glycine Cle...Yvonne Lamers, Jerry Williamson, Maria Ralat, Eoin P. Quinlivan, Lesa R. Gilbert
The Journal of Nutrition. 2009-03-01 - 51 citationsGlycine Turnover and Decarboxylation Rate Quantified in Healthy Men and Women Using Primed, Constant Infusions of [1,2-13C2]Glycine and [2H3]LeucineYvonne Lamers, Jerry Williamson, Lesa R. Gilbert, Peter W. Stacpoole, Jesse F. Gregory
The Journal of Nutrition. 2007-12-01
Press Mentions
- NanoView Biosciences Announces Key Appointments to Scientific Advisory BoardAugust 19th, 2021
- NanoView, Beth Israel Deaconess Medical Center Launch Immuno-Oncology Biomarker StudyApril 15th, 2021